SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is currently trending as investors monitor its resilience amid macroeconomic volatility and ongoing debates surrounding the impact of potential tariff refunds on retail pricing. The community remains focused on Costco's defensive strengths, with frequent discussions centered on its robust membership renewal rates, traffic growth, and valuation relative to the broader consumer staples sector.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is generating significant investor interest driven by high trading volumes, active momentum in its clinical-stage pipeline, and multiple analyst endorsements from firms like Guggenheim and HC Wainwright. Community discussion is focused on the high-stakes Phase 2 LOTUS trial readout expected in 2026 and ongoing debates regarding the company's financial risk profile versus the potential upside of its immunology platform.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for the community due to renewed institutional interest, shifting ecosystem management, and ongoing discussions regarding its quantum-resistant technology. While some traders debate the asset's long-term viability following historic price volatility, active participants are heavily focused on potential regulatory catalysts and the ongoing expansion of its real-world asset (RWA) utility.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is capturing investor attention as they rotate toward defensive, value-oriented positions amidst broader market volatility. The community is actively debating the fund's resilience, with many investors maintaining a long-term 'buy and hold' strategy despite recent stagnant performance, while others monitor the ETF's sector diversification and dividend growth potential as a reliable hedge.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community speculates on a major upcoming partnership announcement, with many pointing to a connection with Stellar or a potential collaboration with Ripple/XRP at an upcoming industry event. Investors are actively debating the project's long-term utility in global payroll and real-world adoption, balancing high-conviction sentiment against skepticism regarding its price performance and market volatility.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh the potential impact of looming pharmaceutical tariffs, which are pushing the company to increase its U.S. manufacturing footprint. Simultaneously, the community is actively debating the company's aggressive M&A strategy, particularly its focus on expanding oncology and T-cell engager therapy pipelines, while keeping a watchful eye on patent litigation risks.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community debates its long-term viability, with supporters pointing to upcoming regulatory clarity like the Clarity Act and existing infrastructure partnerships, while skeptics emphasize a prolonged downward price trend and lack of active communication from project leadership.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a primary focal point of market discourse following the FDA approval of Foundayo, its once-daily oral GLP-1 weight-loss pill, which analysts view as a major step toward expanding the obesity treatment market through improved convenience and scalability. While community discussion remains intense regarding its competitive positioning against Novo Nordisks oral offerings, the broader pharma sector is also digesting the implications of potential new pharmaceutical tariff policies and ongoing M&A activity, keeping Eli Lillys valuation and long-term growth trajectory at the center of investor focus.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The new deal brings the customer's total orders to about $1.14 million over the past 12 months.</li><li>Recently, the company secured a $1 million license renewal and expansion order from a foreign retail bank.</li><li>BIO-key also recently disclosed a cash position of $2.7 million.</li></ul>BIO-key International Inc (BKYI) on Thursday announced that the cyber-defense unit of a foreign defense ministry has placed a $280,000 order to expand its biometric authentication system to more personnel.BIO-key, however, did not disclose the organization's name but added that it currently supports more than 50,000 licensed users for the ministry. The new deal brings the customer's total orders to about $1.14 million over the past 12 months, with more orders potentially expected.The company said its biometric identity and access management technology allows secure logins without phones, tokens, or removable devices.<a href="https://stocktwits.com/symbol/BKYI">BKYI shares</a> were up 2% at the time of writing.<h2 class="st-heading-2">International Deal Wins Across Multiple Channels</h2>Recently, the company secured a $1.04 million license renewal and expansion order from a foreign retail bank for its biometric identification solution and disclosed that it had a cash position of&nbsp;$2.7 million.Earlier this year, BIO-key announced a strategic partnership with Visualforma, a Portuguese IT solutions provider, to expand advanced identity and access management across Portugal’s public sector. The partnership introduces a new business line focused on municipal councils to strengthen cybersecurity and improve access to digital public services.Under the agreement, Visualforma will deploy BIO-key’s biometric and identity management technologies across Portugal’s public-sector network of more than 250 government organizations. The solutions aim to secure access to digital services, improve cybersecurity controls, and support regulatory compliance across municipalities, schools, and healthcare institutions.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment changed to ‘bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes.One user said its “just a matter of time” before an acquisition offer is made.<stembedurl>https://stocktwits.com/CryptoWiizz/message/646682052</stembedurl>Year-to-date, the stock has gained 30%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

BIO-key Discloses Orders From A ‘Foreign Defense Ministry’ – BKYI Stock Gains 

The company, however, did not disclose the organization's name but stated that it currently supports more than 50,000 licensed users for the ministry. 

Equity

<ul class="summary-bullets"><li>The company’s products will be included in more than 250 government organizations.</li><li>The partnership launches a new business line focused on Portuguese municipal councils.</li><li>The partnership also includes the deployment of BIO-key’s technologies in a major tourist city.</li></ul>Shares of BIO-key International, Inc. (BKYI) shot up more than 70% in pre-market trading on Wednesday after the company announced a strategic partnership with Visualforma, a Portuguese IT solutions firm, to expand advanced identity and access management across Portugal’s public sector.The partnership launches a new business line for the company, focused on Portuguese municipal councils to improve cybersecurity and expand access to digital public services.<h2 class="st-heading-2">Terms Of The Agreement</h2>Under the agreement, Visualforma will help with the rollout of BIO-key’s Identity and Access Management (IAM) and biometric authentication solutions across Portugal’s public-sector ecosystem, which includes more than 250 government organizations. A structured deployment framework is already in place to secure access to critical digital services, enhance cybersecurity controls, and support regulatory compliance across municipalities, schools, and healthcare institutions.The partnership also includes the deployment of BIO-key’s technologies in a major tourist hub, where the solution is already operational. BIO-key has already operationalized its full IAM and biometric portfolio in select municipal environments.“Our platform also supports secure identity verification through integration with the Portuguese Cartão de Cidadão and alignment with eIDAS-compliant electronic identification frameworks, strengthening trust, regulatory compliance, and seamless access to digital public services,” said Alex Rocha, Managing Director, BIO-key International.BIO-key, a cybersecurity firm offering cloud-based, IAM and biometric authentication solutions, has similar partnerships across Vietnam, Denmark, Sweden, Norway, Finland, and certain countries in the Middle East and Africa.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment shifted for <a href="https://stocktwits.com/symbol/BKYI">BKYI</a> to ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/BKYI_jpg_4cb6fe3e63.webp" alt="BKYI.jpg">One user believes that the company is a ‘perfect candidate for acquisition.’<stembedurl>https://stocktwits.com/CryptoWiizz/message/643112707</stembedurl>Another user said the ‘huge’ contract could boost the stock price to $4. It is currently at around $0.9.<stembedurl>https://stocktwits.com/SkyLonger/message/643110788</stembedurl>Over the past year, the stock has shed over 60%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/gev-stock-declines-premarket-after-q4-results/cmyg2v8R4i6">Why Is GEV Stock Drawing Investor Attention Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

This Nano Cap Cybersecurity Stock Surged Over 70% In Pre-Market Today – What Is The Portugal Connection?

BIO-key International announced a partnership with Visualforma to expand advanced identity and access management across Portugal’s public sector.

Top Small Cap Stocks To Watch Now - November 9th

Spring Valley Acquisition, BIO-key International, Motorsport Games, Navitas Semiconductor, and Direxion Daily TSLA Bear 1X Shares are the five Small Cap stocks to watch today, according to...

Promising Small Cap Stocks To Add to Your Watchlist - November 8th

Spring Valley Acquisition, Ondas, BIO-key International, Motorsport Games, and Navitas Semiconductor are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool...

Promising Small Cap Stocks Worth Watching - November 7th

Spring Valley Acquisition, BIO-key International, Motorsport Games, Power Solutions International, Direxion Daily TSLA Bear 1X Shares, Navitas Semiconductor, and Direxion Daily META Bull 2X Shares...

Nano-cap Bio-key International, Inc.’s (BKYI) shares jumped in Friday’s premarket session after the company announced that it regained compliance with the Nasdaq standards for continued listing.Holmdel, New Jersey-based Bio-key said that on April 17, it received a notification from Nasdaq informing it that it was not in compliance with the exchange listing standard regarding timely filing of financial reports.&nbsp;Following the filing of the annual report on Form 10-K for the year ended Dec. 31, 2024, on Wednesday, the company has regained compliance. The company said the Nasdaq informed it about it on Thursday and has deemed that the matter has been closed.Bio-key provides workforce and customer identity and access management (IAM) solutions.&nbsp;On Stocktwits, retail sentiment toward Bio-key stock turned to ‘bullish’ (72/100) by early Friday from ‘bearish’ a day ago, while the message volume spurted to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:638/139;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_25_at_4_47_24_AM_png_3b88bc1dd5.webp" alt="Screenshot 2025-04-25 at 4.47.24 AM.png" width="638" height="139"><figcaption>BKYI sentiment and message volume as of 4:48 a.m. ET, April 25 | source: Stocktwits</figcaption></figure>The 24-hour message volume change on the Bio-key stock stream was 2,500% by late Thursday.A bullish watcher said he would hold the Bio-key stock going into Friday’s session.<stembedurl>https://stocktwits.com/walfofwallstreet/message/612638178</stembedurl>Another user predicted that the penny stock would climb to $5.<stembedurl>https://stocktwits.com/WhiskeynBlues/message/612635212</stembedurl>In early premarket trading, <a href="https://stocktwits.com/symbol/BKYI">Bio-key stock </a>surged about 20% to $0.8987. The stock has lost over 56% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/meta-slashes-vr-roles-reality-labs/chQp54LRbWV">Mark Zuckerberg's Meta Slashes VR Roles In Reality Labs: Retail Buzz Rises As Q1 Earnings Day Nears</a>

Rising stock market chart on a trading board background.

Retail Chatter On Bio-key Spikes 2,500% After Identity And Access Management Solutions Company Regains Nasdaq Compliance

Following the filing of the annual report on Form 10-K for the year ended Dec. 31, 2024 on Wednesday, the company has now regained compliance.

BIO-key International, Inc. engages in the provision of an identity and access management platform. The firm's products include PortalGuard, Admin Panel, Hardware, Identity-Bound Biometrics, and MobileAuth. It offers its services to the education, finance, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Holmdel, NJ.

Bio-Key International Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

BKYI
Bio-Key International Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BKYI News

BKYIBio-Key International Inc.